because fresh colon carcinoma cells appear to be resistant to in vitro lysis by interleukin 2-activated tumor-infiltrating lymphocyte and autologous peripheral blood lymphocyte effectors , the role of adoptive immuno-therapy in treatment of advanced colon carcinomas in humans may have to be reevaluated .
C0021756
interleukin 2
C0086418
humans